- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 243/00 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07D 243/00
Total number of patents in this class: 35
10-year publication summary
3
|
4
|
1
|
2
|
0
|
2
|
0
|
1
|
1
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Merck Sharp & Dohme B.V. | 531 |
3 |
Merck Sharp & Dohme LLC | 3751 |
3 |
Hoffmann-La Roche Inc. | 3267 |
2 |
Bayer Pharma AG | 1085 |
2 |
Merck Sharp & Dohme Corp. | 2219 |
1 |
Boehringer Ingelheim International GmbH | 4754 |
1 |
Commissariat à l'énergie atomique et aux energies alternatives | 10692 |
1 |
Vertex Pharmaceuticals Incorporated | 1568 |
1 |
Actavis Group PTC ehf | 509 |
1 |
ArQule, Inc. | 139 |
1 |
Attenuon, LLC | 10 |
1 |
Dana-Farber Cancer Institute, Inc. | 2535 |
1 |
Dart NeuroScience, LLC | 45 |
1 |
Debiopharm International SA | 130 |
1 |
Essilor International (compagnie Generale D'optique) | 2956 |
1 |
Forest Laboratories Holdings Limited | 76 |
1 |
Gilead Sciences, Inc. | 1951 |
1 |
Industry-university Cooperation Foundation Hanyang University Erica Campus | 555 |
1 |
Jubilant Organosys Limited | 29 |
1 |
Medshine Discovery Inc. | 607 |
1 |
Other owners | 9 |